| |NOVEMBER 20244India's pharmaceutical intermediates market has seen an exponential rise, mainly due to a blend of factors including an increasing API demand and strategic governmental support. This segment offers the key compounds on which final pharmaceutical products are based. India's huge API production sector has a high reliance on intermediates and the country can be a global player in the pharmaceutical manufacturing and supply segment. Robust demand for intermediates used in the production of therapeutic drugs, antibiotics, antivirals and cardiovascular treatments is fuelling India's market growth, which aligns with a global trend of higher healthcare spending. The pandemic also brought to the forefront the importance of self-reliance in the pharmaceutical supply chains and India's emphasis on and expansion of domestic intermediate production. Production Linked Incentive (PLI) scheme by government has helped these efforts by offering financial incentives to encourage local manufacturing. The shift in this policy not only reduces dependency of imported raw materials but also consolidates India`s status as a global supplier of high quality intermediates. From the industrial side, progress in biotechnology and chemical synthesis has improved the efficiency of production of intermediates, and research and development introduces eco-friendly and cost effective production. Moreover, industry is expanding as multinational pharmaceutical companies are outsourcing intermediate production from India to its competitive cost and technical expertise. The Indian pharmaceutical intermediates market is expected to maintain a robust growth rate in future on the back of ongoing investment, growing infrastructure and favorable regulatory policies. This momentum gives India the opportunity to play a key role in the global pharmaceutical landscape and achieves great breakthroughs in innovation and supply chain resilience. Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback and suggestions. Sudhakar SinghManaging Editoreditor@indiapharmaoutlook.comFueling the Future of Medicine Vol 2 · Issue 8 - 11 · November, 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial TeamViswanathan AThiruamuthan T K GM - Media & Graphic Designing VisualizerPrabhu DuttaSenior DesignerRajesh R BDesignerAntony Arnold F Suanya BanerjeeAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Precision Fototype Services at Sri Sabari Shopping Complex, 24 Residency Road Bangalore-560025 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.
< Page 3 | Page 5 >